Jeffrey W. Mecaskey

Technical Lead, Health Economics and Planning 

Jeffrey Mecaskey is an HPI Partner and served as Managing Director of Health Partners International from 2009 to 2013. He has 35 years’ experience in international development with a focus on health and political economics, health policy and management. He has expertise in research portfolio development and management as well as planning, implementation and evaluation of health programmes. He was chair of the programme management board for the UK aid funded Improving Access to Health Care for the Poor, Northern Uganda (NU Health), and Senior Technical Expert and Consortium Lead on the EU-funded EU-Strengthening Immunisation Governance in Nigeria (EU-SIGN) and Maximising the Quality of Scaling Up Nutrition + (MQSUN+) programme. He is also leading on a global organisational effectiveness review for UNDP Bureau of Policy and Programme Support.

Background and relevant experience

Before joining HPI, Jeff was Head of Health and HIV at Save the Children UK (2006-8) where he oversaw the organisation’s health and HIV portfolios. During this time he played a pivotal role in the formulation of Save the Children’s policy and strategy focus on health equity and health system strengthening to secure child rights worldwide.

Previously, Jeff served as Vice President of Operations at Axios International in France (2004-5) where he managed the organisation’s consultancy operations. He also oversaw the organisational development of a sister NGO to model improved chronic disease management such as HIV/AIDS in Africa and similar resource-constrained settings.

Prior to this, Jeff was Vice President of Programs at the International Trachoma Initiative in the United States from 1998 until 2004 where he oversaw in planning, implementation and evaluation of the global initiative to eliminate blinding trachoma through national programming, operational research and targeted communications. From 1990 to 1997, Jeff was Associate at the Edna McConnell Clark Foundation where he co-directed a $4 million per annum grant making program to improve health in Africa.

Between 1989 and 1990, Jeff operated as a consultant on economic analyses, management training and pharmaceutical policy for the Harvard Institute for International Development. During this time he was involved in curriculum development and taught health economics at Harvard School of Public Health. He also worked as a consultant for John Snow Inc. in developing financial models for immunisation programmes.

Jeff has served on a number of board and scientific committees.  He serves on the boards of charitable HPI Institute, Transaid and the Britain Nepal Medical Trust (Chair: 2005-10). Others include, Woman’s Dignity, a Tanzanian-based NGO focused on the prevention and management obstetric fistula as an entry point to sexual and reproductive health rights and equity (Treasurer: 2008-11), and RAINBO, an African-led NGO involved in women’s empowerment, sexual and reproductive rights, for which he was Chair from 2002-2006. He was a member of the Oxford University Global Governance Initiative and on its committee governance and globalisation (2006-11).

A member of the UK Faculty of Public Health, Jeff studied for a Doctorate in Health Economics and a Master of Science in Health policy and Management from Harvard T.H. Chan School of Public Health. Jeff has a number of publications on health economics, health policy and disease control. His publications include an IDS Working Paper on Ebola and health system resilience, an assessment of the importance of equity in reaching the Millennium Development Goals, published in PLOS/Medicine, and a chapter on the Loss of Vision and Hearing in Disease Control Priorities in Developing Countries.

Jeff has consulted and worked in Bangladesh, Cameroon, China, Egypt, Ethiopia, Gambia, Ghana, Kenya, Mali, Mauritania, Morocco, Mozambique, Nepal, Niger, Nigeria, Senegal, South Africa, Tanzania, Vietnam, Zambia and Zimbabwe, as well as France, UK, and USA.

Selected Publications, presentations and reports


Andrew McKenzie, Ahmad Abdulwahab, Emmanuel Sokpo and Jeffrey W Mecaskey (2016) ‘Creating the foundations for Health Systems Resilience in Northern Nigeria’ Health Systems & Reform, 2(4):1163-4

Tendayi Kureya, Kristina Zetterlund, and Jeffrey Mecaskey (2010). ‘Zimbabwe’s Health Sector: The Way Forward’, The Lancet 375(9721):1163-4.

Daniel D. Reidpath, Chantel M. Morel, Jeffrey W. Mecaskey and Pascale Allotey (2009) ‘The Millenium Development Goals Fail Poor Children: The Case for Equity-Adjusted Measures’. PLoS Med 6:1-3.

Joseph Cook, Kevin D Frick, Rob Baltussen, Serge Resnikoff, Andrew Smith, Jeffrey Mecaskey and Peter Kilima Loss of Vision and Hearing. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease Control Priorities in Developing Countries. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.

Jeffrey Mecaskey, Edith Ngirwamungu and Peter M Kilima (2003) ‘Integration of Trachoma Control into Primary Healthcare: the Tanzanian Experience’ The American Journal of Tropical Medicine and Hygiene 69 (5):24-8.

Jacob A. Kumeresan and Jeffrey W Mecaskey (2003) ‘The global elimination of Blinding Trachoma: Progress and Promise’, The American Journal of Tropical Medicine and Hygiene 69(5): 24-8

Jeffrey W Mecaskey, Charles A. Knirsch, Jacob A. Kumeresan and Dr Joseph A. Cook (2003) ‘ The possibility of eliminating blinding trachoma’, Lancet Infectious Diseases 3 (11): 728:34

Eva V Basilion, Peter M Kilima, Virginia M Turner and Jeffrey W Mecaskey (2002) ‘Height as a proxy weight in determining azithromycin treatment for paediatric trachoma’, Trans R Soc Trop Med Hyg 96(6): 691-4


‘Political Economy of Financing for Healthcare Development’. Presented at University of Sussex Development Conference, Brighton: April 2016

‘Global Health Architecture: Roles, Responsibilities and Policies’ and ‘Strengthening Health Systems for Access and Resilience’. Presented at the IDS Flagship Course. Brighton, Nov 2015

‘Payment by Results: Learning from NU Health’. Presented at the DFID Advisors Series. London: Feb 2016.

Results-Based Financing & Its Systems Implications’. Presented at the DFID Advisors Series. London: Oct 2015.


Results Based Financing Part 1: From revolutionary to routine

Results Based Financing Part 2: No Systems, No Scale